Abstract
Expression of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase associated with cell proliferation and survival, is overactive in many tumors of epithelial origin. Blockade of the kinase activity of EGFR has been used for cancer therapy; however, by itself, it does not seem to reach maximum therapeutic efficacy. We report here that in human cancer cells, the function of kinase-independent EGFR is to prevent autophagic cell death by maintaining intracellular glucose level through interaction and stabilization of the sodium/glucose cotransporter 1 (SGLT1).
Original language | English |
---|---|
Pages (from-to) | 385-393 |
Number of pages | 9 |
Journal | Cancer Cell |
Volume | 13 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2008 |
Externally published | Yes |
Keywords
- CELLBIO
- CELLCYCLE
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research